Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study
Gespeichert in:
Veröffentlicht in: | Ophthalmology (Rochester, Minn.) Minn.), 2013-09, Vol.120 (9), p.1944-1945.e1 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1945.e1 |
---|---|
container_issue | 9 |
container_start_page | 1944 |
container_title | Ophthalmology (Rochester, Minn.) |
container_volume | 120 |
creator | Tufail, Adnan, MD, FRCOphth Narendran, Nirodhini, MD, FRCOphth Patel, Praveen J., MBBS, FRCOphth, MD(Res) Sivaprasad, Sobha, DM, FRCS Amoaku, Winfried, MBBS, FRCOphth Browning, Andrew C., BM, FRCOphth Osoba, Olayinka, MBBS, FRCS(Ed) Gale, Richard, MBBS, MRCP, MRCOphth George, Sheena, MBBS, FRCOphth Lotery, Andrew J., MD, FRCOphth Majid, Mohammed, MBBS, FRCOphth McKibbin, Martin, MBBS, FRCOphth Menon, Geeta, MBBS, FRCOphth Andrews, Christopher, CStat Brittain, Christopher, MBBS, MRCOphth Osborne, Aaron, MBBS, MRCOphth Yang, Yit, MBChB, FRCOphth |
description | |
doi_str_mv | 10.1016/j.ophtha.2013.06.010 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1430395521</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0161642013005010</els_id><sourcerecordid>1430395521</sourcerecordid><originalsourceid>FETCH-LOGICAL-c483t-31161bac01553fbb5d066c93f770d1d068fd3bd29d5b426878e945df2ed4b81d3</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EokvhHyDkI5eE8Vc24YBUrQpU6pe25Yrl2I7iJYkX26m0_fV1tIUDF04ja9555_UzCL0nUBIg1add6fd96lVJgbASqhIIvEArInhT8DVhL9Eqy0hRcQon6E2MOwCoKsZfoxPKAYhgdIV-btXkWvc4j6rFbsJXB793Gm96H7wzasDX1j-oqOdBBfeokvPTZ3zfW0xoceWn1OOtjfOQIu6CH3HKne357dnFFt-l2RzeoledGqJ991xP0Y-v5_eb78XlzbeLzdlloXnNUsFITtoqnUMJ1rWtMDmpbli3XoMh-VF3hrWGNka0nFb1urYNF6aj1vC2Joadoo9H333wv2cbkxxd1HYY1GT9HCXhDFgjBCVZyo9SHXyMwXZyH9yowkESkAtZuZNHsnIhK6GSmWwe-_C8YW5Ha_4O_UGZBV-OApv_-eBskFE7O2lrXLA6SePd_zb8a6AHNzmthl_2YOPOz2HKDCWRkUqQd8t1l-MSBiAWgydTzZ-I</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1430395521</pqid></control><display><type>article</type><title>Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Tufail, Adnan, MD, FRCOphth ; Narendran, Nirodhini, MD, FRCOphth ; Patel, Praveen J., MBBS, FRCOphth, MD(Res) ; Sivaprasad, Sobha, DM, FRCS ; Amoaku, Winfried, MBBS, FRCOphth ; Browning, Andrew C., BM, FRCOphth ; Osoba, Olayinka, MBBS, FRCS(Ed) ; Gale, Richard, MBBS, MRCP, MRCOphth ; George, Sheena, MBBS, FRCOphth ; Lotery, Andrew J., MD, FRCOphth ; Majid, Mohammed, MBBS, FRCOphth ; McKibbin, Martin, MBBS, FRCOphth ; Menon, Geeta, MBBS, FRCOphth ; Andrews, Christopher, CStat ; Brittain, Christopher, MBBS, MRCOphth ; Osborne, Aaron, MBBS, MRCOphth ; Yang, Yit, MBChB, FRCOphth</creator><creatorcontrib>Tufail, Adnan, MD, FRCOphth ; Narendran, Nirodhini, MD, FRCOphth ; Patel, Praveen J., MBBS, FRCOphth, MD(Res) ; Sivaprasad, Sobha, DM, FRCS ; Amoaku, Winfried, MBBS, FRCOphth ; Browning, Andrew C., BM, FRCOphth ; Osoba, Olayinka, MBBS, FRCS(Ed) ; Gale, Richard, MBBS, MRCP, MRCOphth ; George, Sheena, MBBS, FRCOphth ; Lotery, Andrew J., MD, FRCOphth ; Majid, Mohammed, MBBS, FRCOphth ; McKibbin, Martin, MBBS, FRCOphth ; Menon, Geeta, MBBS, FRCOphth ; Andrews, Christopher, CStat ; Brittain, Christopher, MBBS, MRCOphth ; Osborne, Aaron, MBBS, MRCOphth ; Yang, Yit, MBChB, FRCOphth</creatorcontrib><identifier>ISSN: 0161-6420</identifier><identifier>EISSN: 1549-4713</identifier><identifier>DOI: 10.1016/j.ophtha.2013.06.010</identifier><identifier>PMID: 24001532</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Angiogenesis Inhibitors - therapeutic use ; Antibodies, Monoclonal, Humanized - therapeutic use ; Choroidal Neovascularization - diagnosis ; Choroidal Neovascularization - drug therapy ; Choroidal Neovascularization - etiology ; Female ; Follow-Up Studies ; Humans ; Intravitreal Injections ; Male ; Middle Aged ; Myopia, Degenerative - complications ; Myopia, Degenerative - diagnosis ; Myopia, Degenerative - drug therapy ; Ophthalmology ; Prospective Studies ; Ranibizumab ; Tomography, Optical Coherence ; Treatment Outcome ; Visual Acuity - physiology</subject><ispartof>Ophthalmology (Rochester, Minn.), 2013-09, Vol.120 (9), p.1944-1945.e1</ispartof><rights>American Academy of Ophthalmology</rights><rights>2013 American Academy of Ophthalmology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c483t-31161bac01553fbb5d066c93f770d1d068fd3bd29d5b426878e945df2ed4b81d3</citedby><cites>FETCH-LOGICAL-c483t-31161bac01553fbb5d066c93f770d1d068fd3bd29d5b426878e945df2ed4b81d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0161642013005010$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24001532$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tufail, Adnan, MD, FRCOphth</creatorcontrib><creatorcontrib>Narendran, Nirodhini, MD, FRCOphth</creatorcontrib><creatorcontrib>Patel, Praveen J., MBBS, FRCOphth, MD(Res)</creatorcontrib><creatorcontrib>Sivaprasad, Sobha, DM, FRCS</creatorcontrib><creatorcontrib>Amoaku, Winfried, MBBS, FRCOphth</creatorcontrib><creatorcontrib>Browning, Andrew C., BM, FRCOphth</creatorcontrib><creatorcontrib>Osoba, Olayinka, MBBS, FRCS(Ed)</creatorcontrib><creatorcontrib>Gale, Richard, MBBS, MRCP, MRCOphth</creatorcontrib><creatorcontrib>George, Sheena, MBBS, FRCOphth</creatorcontrib><creatorcontrib>Lotery, Andrew J., MD, FRCOphth</creatorcontrib><creatorcontrib>Majid, Mohammed, MBBS, FRCOphth</creatorcontrib><creatorcontrib>McKibbin, Martin, MBBS, FRCOphth</creatorcontrib><creatorcontrib>Menon, Geeta, MBBS, FRCOphth</creatorcontrib><creatorcontrib>Andrews, Christopher, CStat</creatorcontrib><creatorcontrib>Brittain, Christopher, MBBS, MRCOphth</creatorcontrib><creatorcontrib>Osborne, Aaron, MBBS, MRCOphth</creatorcontrib><creatorcontrib>Yang, Yit, MBChB, FRCOphth</creatorcontrib><title>Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study</title><title>Ophthalmology (Rochester, Minn.)</title><addtitle>Ophthalmology</addtitle><subject>Aged</subject><subject>Angiogenesis Inhibitors - therapeutic use</subject><subject>Antibodies, Monoclonal, Humanized - therapeutic use</subject><subject>Choroidal Neovascularization - diagnosis</subject><subject>Choroidal Neovascularization - drug therapy</subject><subject>Choroidal Neovascularization - etiology</subject><subject>Female</subject><subject>Follow-Up Studies</subject><subject>Humans</subject><subject>Intravitreal Injections</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Myopia, Degenerative - complications</subject><subject>Myopia, Degenerative - diagnosis</subject><subject>Myopia, Degenerative - drug therapy</subject><subject>Ophthalmology</subject><subject>Prospective Studies</subject><subject>Ranibizumab</subject><subject>Tomography, Optical Coherence</subject><subject>Treatment Outcome</subject><subject>Visual Acuity - physiology</subject><issn>0161-6420</issn><issn>1549-4713</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EokvhHyDkI5eE8Vc24YBUrQpU6pe25Yrl2I7iJYkX26m0_fV1tIUDF04ja9555_UzCL0nUBIg1add6fd96lVJgbASqhIIvEArInhT8DVhL9Eqy0hRcQon6E2MOwCoKsZfoxPKAYhgdIV-btXkWvc4j6rFbsJXB793Gm96H7wzasDX1j-oqOdBBfeokvPTZ3zfW0xoceWn1OOtjfOQIu6CH3HKne357dnFFt-l2RzeoledGqJ991xP0Y-v5_eb78XlzbeLzdlloXnNUsFITtoqnUMJ1rWtMDmpbli3XoMh-VF3hrWGNka0nFb1urYNF6aj1vC2Joadoo9H333wv2cbkxxd1HYY1GT9HCXhDFgjBCVZyo9SHXyMwXZyH9yowkESkAtZuZNHsnIhK6GSmWwe-_C8YW5Ha_4O_UGZBV-OApv_-eBskFE7O2lrXLA6SePd_zb8a6AHNzmthl_2YOPOz2HKDCWRkUqQd8t1l-MSBiAWgydTzZ-I</recordid><startdate>20130901</startdate><enddate>20130901</enddate><creator>Tufail, Adnan, MD, FRCOphth</creator><creator>Narendran, Nirodhini, MD, FRCOphth</creator><creator>Patel, Praveen J., MBBS, FRCOphth, MD(Res)</creator><creator>Sivaprasad, Sobha, DM, FRCS</creator><creator>Amoaku, Winfried, MBBS, FRCOphth</creator><creator>Browning, Andrew C., BM, FRCOphth</creator><creator>Osoba, Olayinka, MBBS, FRCS(Ed)</creator><creator>Gale, Richard, MBBS, MRCP, MRCOphth</creator><creator>George, Sheena, MBBS, FRCOphth</creator><creator>Lotery, Andrew J., MD, FRCOphth</creator><creator>Majid, Mohammed, MBBS, FRCOphth</creator><creator>McKibbin, Martin, MBBS, FRCOphth</creator><creator>Menon, Geeta, MBBS, FRCOphth</creator><creator>Andrews, Christopher, CStat</creator><creator>Brittain, Christopher, MBBS, MRCOphth</creator><creator>Osborne, Aaron, MBBS, MRCOphth</creator><creator>Yang, Yit, MBChB, FRCOphth</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20130901</creationdate><title>Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study</title><author>Tufail, Adnan, MD, FRCOphth ; Narendran, Nirodhini, MD, FRCOphth ; Patel, Praveen J., MBBS, FRCOphth, MD(Res) ; Sivaprasad, Sobha, DM, FRCS ; Amoaku, Winfried, MBBS, FRCOphth ; Browning, Andrew C., BM, FRCOphth ; Osoba, Olayinka, MBBS, FRCS(Ed) ; Gale, Richard, MBBS, MRCP, MRCOphth ; George, Sheena, MBBS, FRCOphth ; Lotery, Andrew J., MD, FRCOphth ; Majid, Mohammed, MBBS, FRCOphth ; McKibbin, Martin, MBBS, FRCOphth ; Menon, Geeta, MBBS, FRCOphth ; Andrews, Christopher, CStat ; Brittain, Christopher, MBBS, MRCOphth ; Osborne, Aaron, MBBS, MRCOphth ; Yang, Yit, MBChB, FRCOphth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c483t-31161bac01553fbb5d066c93f770d1d068fd3bd29d5b426878e945df2ed4b81d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Aged</topic><topic>Angiogenesis Inhibitors - therapeutic use</topic><topic>Antibodies, Monoclonal, Humanized - therapeutic use</topic><topic>Choroidal Neovascularization - diagnosis</topic><topic>Choroidal Neovascularization - drug therapy</topic><topic>Choroidal Neovascularization - etiology</topic><topic>Female</topic><topic>Follow-Up Studies</topic><topic>Humans</topic><topic>Intravitreal Injections</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Myopia, Degenerative - complications</topic><topic>Myopia, Degenerative - diagnosis</topic><topic>Myopia, Degenerative - drug therapy</topic><topic>Ophthalmology</topic><topic>Prospective Studies</topic><topic>Ranibizumab</topic><topic>Tomography, Optical Coherence</topic><topic>Treatment Outcome</topic><topic>Visual Acuity - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tufail, Adnan, MD, FRCOphth</creatorcontrib><creatorcontrib>Narendran, Nirodhini, MD, FRCOphth</creatorcontrib><creatorcontrib>Patel, Praveen J., MBBS, FRCOphth, MD(Res)</creatorcontrib><creatorcontrib>Sivaprasad, Sobha, DM, FRCS</creatorcontrib><creatorcontrib>Amoaku, Winfried, MBBS, FRCOphth</creatorcontrib><creatorcontrib>Browning, Andrew C., BM, FRCOphth</creatorcontrib><creatorcontrib>Osoba, Olayinka, MBBS, FRCS(Ed)</creatorcontrib><creatorcontrib>Gale, Richard, MBBS, MRCP, MRCOphth</creatorcontrib><creatorcontrib>George, Sheena, MBBS, FRCOphth</creatorcontrib><creatorcontrib>Lotery, Andrew J., MD, FRCOphth</creatorcontrib><creatorcontrib>Majid, Mohammed, MBBS, FRCOphth</creatorcontrib><creatorcontrib>McKibbin, Martin, MBBS, FRCOphth</creatorcontrib><creatorcontrib>Menon, Geeta, MBBS, FRCOphth</creatorcontrib><creatorcontrib>Andrews, Christopher, CStat</creatorcontrib><creatorcontrib>Brittain, Christopher, MBBS, MRCOphth</creatorcontrib><creatorcontrib>Osborne, Aaron, MBBS, MRCOphth</creatorcontrib><creatorcontrib>Yang, Yit, MBChB, FRCOphth</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Ophthalmology (Rochester, Minn.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tufail, Adnan, MD, FRCOphth</au><au>Narendran, Nirodhini, MD, FRCOphth</au><au>Patel, Praveen J., MBBS, FRCOphth, MD(Res)</au><au>Sivaprasad, Sobha, DM, FRCS</au><au>Amoaku, Winfried, MBBS, FRCOphth</au><au>Browning, Andrew C., BM, FRCOphth</au><au>Osoba, Olayinka, MBBS, FRCS(Ed)</au><au>Gale, Richard, MBBS, MRCP, MRCOphth</au><au>George, Sheena, MBBS, FRCOphth</au><au>Lotery, Andrew J., MD, FRCOphth</au><au>Majid, Mohammed, MBBS, FRCOphth</au><au>McKibbin, Martin, MBBS, FRCOphth</au><au>Menon, Geeta, MBBS, FRCOphth</au><au>Andrews, Christopher, CStat</au><au>Brittain, Christopher, MBBS, MRCOphth</au><au>Osborne, Aaron, MBBS, MRCOphth</au><au>Yang, Yit, MBChB, FRCOphth</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study</atitle><jtitle>Ophthalmology (Rochester, Minn.)</jtitle><addtitle>Ophthalmology</addtitle><date>2013-09-01</date><risdate>2013</risdate><volume>120</volume><issue>9</issue><spage>1944</spage><epage>1945.e1</epage><pages>1944-1945.e1</pages><issn>0161-6420</issn><eissn>1549-4713</eissn><cop>United States</cop><pub>Elsevier Inc</pub><pmid>24001532</pmid><doi>10.1016/j.ophtha.2013.06.010</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0161-6420 |
ispartof | Ophthalmology (Rochester, Minn.), 2013-09, Vol.120 (9), p.1944-1945.e1 |
issn | 0161-6420 1549-4713 |
language | eng |
recordid | cdi_proquest_miscellaneous_1430395521 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Aged Angiogenesis Inhibitors - therapeutic use Antibodies, Monoclonal, Humanized - therapeutic use Choroidal Neovascularization - diagnosis Choroidal Neovascularization - drug therapy Choroidal Neovascularization - etiology Female Follow-Up Studies Humans Intravitreal Injections Male Middle Aged Myopia, Degenerative - complications Myopia, Degenerative - diagnosis Myopia, Degenerative - drug therapy Ophthalmology Prospective Studies Ranibizumab Tomography, Optical Coherence Treatment Outcome Visual Acuity - physiology |
title | Ranibizumab in Myopic Choroidal Neovascularization: The 12-Month Results from the REPAIR Study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T16%3A59%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ranibizumab%20in%20Myopic%20Choroidal%20Neovascularization:%20The%2012-Month%20Results%20from%20the%20REPAIR%20Study&rft.jtitle=Ophthalmology%20(Rochester,%20Minn.)&rft.au=Tufail,%20Adnan,%20MD,%20FRCOphth&rft.date=2013-09-01&rft.volume=120&rft.issue=9&rft.spage=1944&rft.epage=1945.e1&rft.pages=1944-1945.e1&rft.issn=0161-6420&rft.eissn=1549-4713&rft_id=info:doi/10.1016/j.ophtha.2013.06.010&rft_dat=%3Cproquest_cross%3E1430395521%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1430395521&rft_id=info:pmid/24001532&rft_els_id=S0161642013005010&rfr_iscdi=true |